Indraprastha Medical Corporation Limited (INDRAMEDCO) — Announcement | 19 June 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

About Indraprastha Medical Corporation Limited (INDRAMEDCO)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹3,279.6 Cr P/E: 17.4 ROE: 31.5% ROCE: 43.4% Div Yield: 1.12%

View full INDRAMEDCO stock details →

📡 Get AI alerts when INDRAMEDCO files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track INDRAMEDCO — Free

📊 More INDRAMEDCO filings

See all INDRAMEDCO filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when INDRAMEDCO files new disclosures

Track INDRAMEDCO filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track INDRAMEDCO — Free

Free account · 2 AI queries/day